Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2018

Open Access 01-12-2018 | Study protocol

Self-monitoring and personalized feedback based on the experiencing sampling method as a tool to boost depression treatment: a protocol of a pragmatic randomized controlled trial (ZELF-i)

Authors: Jojanneke A. Bastiaansen, Maaike Meurs, Renee Stelwagen, Lex Wunderink, Robert A. Schoevers, Marieke Wichers, Albertine J. Oldehinkel

Published in: BMC Psychiatry | Issue 1/2018

Login to get access

Abstract

Background

Depression is a leading cause of disability worldwide. To reduce the societal burden and improve quality of life for individual patients, treatments for depression need to be optimized. There is a particular need for person-tailored interventions that reinforce self-management of patients. Systematic self-monitoring and personalized feedback through the Experience Sampling Method (ESM) could provide such a person-tailored, empowering intervention that enhances treatment outcomes. The primary aim of this study is to investigate the efficacy of self-monitoring and personalized feedback as an add-on tool in the treatment of depressive complaints in a natural setting.

Methods

The ZELF-i study is a pragmatic multi-site randomized controlled trial (RCT). We aim to recruit 150 individuals with depressive symptoms aged between 18 and 65 years, who have an intake for outpatient basic or specialized treatment at a mental health care organization in the North of the Netherlands. After the intake, participants will be randomly allocated to one of three study arms: two experimental groups engaging in 28 days of systematic self-monitoring (5 times per day) and receiving weekly personalized feedback on positive affect and activities (“Do”-module) or on negative affect and thinking patterns (“Think”-module), and a control group receiving no additional intervention. Self-report inventories of depressive symptoms, psychosocial functioning and feelings of empowerment will be administered before and after the intervention period, and at follow-up measurements at 1, 2, 3 and 6 months. The patient-experienced utility of the intervention will be investigated by a combination of quantitative and qualitative research methods.

Discussion

The present study is the first to examine the effects of add-on self-monitoring and personalized feedback on depressive complaints in clinical practice. It is also the first to evaluate two different ESM modules targeted at both of depression’s core symptoms. Lastly, it is the first study that uses a combination of qualitative and quantitative methods to evaluate the patient-experienced utility of ESM with personalized feedback as an intervention for depression. Results of the present study may improve treatment for depression, if the intervention is found to be effective.

Trial registration

Dutch Trial Register, NTR5707, registered prospectively 1 February 2016.
Appendix
Available only for authorised users
Literature
1.
2.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text revision. Washington, DC: American Psychiatric Association; 2000.
3.
4.
Elfeddali I, van der Feltz-Cornelis CM, van Os J, Knappe S, Vieta E, Wittchen HU, et al. Horizon 2020 priorities in clinical mental health research: results of a consensus-based ROAMER expert survey. Int J Environ Res Public Health. 2014;11(10):10915–39.CrossRefPubMedPubMedCentral
5.
Myin-Germeys I, Oorschot M, Collip D, Lataster J, Delespaul P, van Os J. Experience sampling research in psychopathology: opening the black box of daily life. Psychol Med. 2009;39:1533–47.CrossRefPubMed
6.
Larson R, Csikszentmihalyi M. The experience sampling method. In: Reis HT, editor. New directions for methodology of social and behavioral sciences. San Francisco: Jossey-Bass; 1983. p. 41–56.
7.
Aan het Rot M, Hogenelst K, Schoevers RA. Mood disorders in everyday life: a systematic review of experience sampling and ecological momentary assessment studies. Clin Psychol Rev. 2012;32(6):510–23.
8.
Telford C, McCarthy-Jones S, Corcoran R, Rowse G. Experience sampling methodology studies of depression: the state of the art. Psychol Med. 2012;42(6):1119–29.CrossRefPubMed
9.
van Os J, Delespaul P, Wigman J, Myin-Germeys I, Wichers M. Beyond DSM and ICD: introducing “precision diagnosis” for psychiatry using momentary assessment technology. World Psychiatry. 2013;12(2):113–7.CrossRefPubMedPubMedCentral
10.
Groot PC. Patients can diagnose too: how continuous self-assessment aids diagnosis of, and recovery from, depression. J Ment Health. 2010;19(4):352–62.CrossRefPubMed
11.
Myin-Germeys I, Klippel A, Steinhart H, Reininghaus U. Ecological momentary interventions in psychiatry. Curr Opin Psychiatry. 2016;29(4):258–63.CrossRefPubMed
12.
13.
Rosmalen JG, Wenting AM, Roest AM, de Jonge P, Bos EH. Revealing causal heterogeneity using time series analysis of ambulatory assessments: application to the association between depression and physical activity after myocardial infarction. Psychosom Med. 2012;74(4):377–86.CrossRefPubMed
14.
Kauer SD, Reid SC, Crooke AH, Khor A, Hearps SJ, Jorm AF, et al. Self-monitoring using mobile phones in the early stages of adolescent depression: randomized controlled trial. J Med Internet Res. 2012;14(3):e67.CrossRefPubMedPubMedCentral
15.
Kramer I, Simons CJ, Hartmann JA, Menne-Lothmann C, Viechtbauer W, Peeters F, et al. A therapeutic application of the experience sampling method in the treatment of depression: a randomized controlled trial. World Psychiatry. 2014;13(1):68–77.CrossRefPubMedPubMedCentral
16.
Beck AT, Rush AJ, Shaw B, Emery G. Cognitive therapy of depression. New York: Guilford Press; 1987.
17.
Simons CJ, Hartmann JA, Kramer I, Menne-Lothmann C, Höhn P, van Bemmel AL, et al. Effects of momentary self-monitoring on empowerment in a randomized controlled trial in patients with depression. Eur Psychiatry. 2015;30(8):900–6.CrossRefPubMed
18.
19.
Torous J, Chan SR, Yee-Marie Tan S, Behrens J, Mathew I, Conrad EJ, et al. Patient smartphone ownership and interest in mobile apps to monitor symptoms of mental health conditions: a survey in four geographically distinct psychiatric clinics. JMIR Mental Health. 2014;1(1):e5.CrossRefPubMedPubMedCentral
20.
Burgers JS, JJE VE. Evidence-based guideline development in the Netherlands: the EBRO platform. Ned Tijdschr Geneeskd. 2004;148(42):2057–9.PubMed
21.
Snippe E, Simons CJP, Hartmann JA, Menne-Lothmann C, Kramer I, Booij SH, et al. Change in daily life behaviors and depression: within-person and between-person associations. Health Psychol. 2016;35(5):433–41.CrossRefPubMed
22.
Boevink W. Samen werken aan herstel. Van ervaringen delen naar kennis overdragen. Utrecht: Trimbos-instituut; 2002.
23.
Huber M, Knottnerus JA, Green L, van der Horst H, Jadad AR, Kromhout D, et al. How should we define health? BMJ. 2011;343:d4163.CrossRefPubMed
24.
Forchuk C, Reiss JP, O'Regan T, Ethridge P, Donelle L, Rudnick A. Client perceptions of the mental health engagement network: a qualitative analysis of an electronic personal health record. BMC Psychiatry. 2015;15:250.CrossRefPubMedPubMedCentral
25.
26.
van Grieken RA, Kirkenier AC, Koeter MW, Nabitz UW, Schene AH. Patients’ perspective on self-management during recovery from depression. Ned Tijdschr Geneeskd. 2012;156(19):A4337.PubMed
27.
Chambers E, Cook S, Thake A, Foster A, Shaw S, Hutten R. The self-management of longer-term depression: learning from the patient, a qualitative study. BMC Psychiatry. 2015;15:172.CrossRefPubMedPubMedCentral
28.
Hoffmann T, Glasziou P, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.CrossRefPubMed
29.
Brandt PT, Williams JT. Multiple time series models. Series: quantitative applications in the social sciences. Thousand Oaks: Sage Publications; 2007.CrossRef
30.
Van der Krieke L, Emerencia AC, Bos EH, Rosmalen JG, Riese H, Aiello M, et al. Ecological momentary assessments and automated time series analysis to promote tailored health care: a proof-of-principle study. JMIR Res Protoc. 2015;4(3):e100.CrossRefPubMedPubMedCentral
31.
Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The inventory of depressive symptomatology (IDS): psychometric properties. Psychol Med. 1996;26(3):477–86.CrossRefPubMed
32.
Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573–83.CrossRefPubMed
33.
Lambert MJ, Burlingame GM, Umphress V, Hansen NB, Vermeersch DA, Clouse GC, et al. The reliability and validity of the outcome questionnaire. Clin Psychol Psychother. 1996;3(4):249–58.CrossRef
34.
Boevink W, Kroon H, Giesen F. De Nederlandse empowerment vragenlijst. Utrecht: Trimbos-instituut; 2008.
35.
Lambert MJ. The outcome Questionnaire-45. In: integrating science and practice. Ordre des psychologues du Quebec. 2012;2(2):24–7.
36.
Hakkaart-van Roijen L. TiC-P: Trimbos/iMTA questionnaire for costs associated with psychiatric illness. Rotterdam: Institute for medical technology assessment; 2002.
37.
Prieto L, Novick D, Sacristán JA, Edgell ET, Alonso J, and on behalf of the SOHO study group. A Rasch model analysis to test the cross-cultural validity of the EuroQoL-5D in the schizophrenia outpatient health outcomes study. Acta Psychiatr Scand. 2003;107:24–9.CrossRef
38.
Simons CJP, Drukker M, Evers S, van Mastrigt GAPG, Höhn P, Kramer I, et al. Economic evaluation of an experience sampling method intervention in depression compared with treatment as usual using data from a randomized controlled trial. BMC Psychiatry. 2017;17(1):415.CrossRefPubMedPubMedCentral
39.
Bagby RM, Parker JDA, Taylor GJ. The twenty-item Toronto alexithymia scale-I. Item selection and cross-validation of the factor structure. J Psychosom Res. 1994;38:23–32.CrossRefPubMed
40.
Bagby RM, Parker JDA, Taylor GJ. The twenty-item Toronto alexithymia scale: II. Convergent, discriminant, and concurrent validity. J Psychosom Res. 1994;38:33–40.CrossRefPubMed
41.
Van der Does W. Cognitive reactivity to sad mood: structure and validity of a new measure. Behav Res Ther. 2002;40(1):105–19.CrossRefPubMed
42.
43.
Ricciardi L, Demartini B, Fotopoulou A, Edwards MJ. Alexithymia in neurological disease: a review. J Neuropsychiatry Clin Neurosci. 2015;27(3):179–87.CrossRefPubMed
44.
Saarijärvi S, Salminen JK, Toikka TB. Alexithymia and depression: a 1-year follow-up study in outpatients with major depression. J Psychosom Res. 2001;51(6):729–33.CrossRefPubMed
45.
Faul F, Erdfelder E, Lang AG, Buchner A. G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–91.CrossRefPubMed
46.
van Gils A, Burton C, Bos EH, Janssens KA, Schoevers RA, Rosmalen JG. Individual variation in temporal relationships between stress and functional somatic symptoms. J Psychosom Res. 2014;77(1):34–9.CrossRefPubMed
47.
Baarda DB, de Goede MPM, Teunissen J. Basisboek kwalitatief onderzoek: handleiding voor het opzetten en uitvoeren van kwalitatief onderzoek. 1st ed. Houten: Stenfert Kroese; 1995.
48.
Boeije H. A purposeful approach to the constant comparative method in the analysis of qualitative interviews. Qual Quant. 2002;36:391–409.CrossRef
49.
Driessen E, Van HL, Don FJ, Peen J, Kool S, Westra D, et al. The efficacy of cognitive-behavioral therapy and psychodynamic therapy in the outpatient treatment of major depression: a randomized clinical trial. Am J Psychiatry. 2013;170:1041–50.CrossRefPubMed
Metadata
Title
Self-monitoring and personalized feedback based on the experiencing sampling method as a tool to boost depression treatment: a protocol of a pragmatic randomized controlled trial (ZELF-i)
Authors
Jojanneke A. Bastiaansen
Maaike Meurs
Renee Stelwagen
Lex Wunderink
Robert A. Schoevers
Marieke Wichers
Albertine J. Oldehinkel
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2018
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-018-1847-z

Other articles of this Issue 1/2018

BMC Psychiatry 1/2018 Go to the issue

Research article

Genotype-dependent associations between serotonin transporter gene (SLC6A4) DNA methylation and late-life depression

Research article

BEATVIC, a body-oriented resilience therapy using kickboxing exercises for people with a psychotic disorder: a feasibility study

Research article

A randomized controlled double-blind clinical trial comparing versus placebo the effect of an edible algal extract (Ulva Lactuca) on the component of depression in healthy volunteers with anhedonia

Research article

Community based telepsychiatry service for older adults residing in a rural and remote region- utilization pattern and satisfaction among stakeholders

Research article

Medication review plus person-centred care: a feasibility study of a pharmacy-health psychology dual intervention to improve care for people living with dementia

Database

Antidepressants for depressive disorder in children and adolescents: a database of randomised controlled trials